Details of the Drug
General Information of Drug (ID: DMDGWAY)
Drug Name |
1-Cyclopentylidenethiosemicarbazide
|
||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Synonyms |
cyclopentanone thiosemicarbazone; 7283-39-8; Hydrazinecarbothioamide, 2-cyclopentylidene-; (cyclopentylideneamino)thiourea; Cyclopentanone, thiosemicarbazone; 1-Cyclopentylidenethiosemicarbazide; 2-cyclopentylidenehydrazinecarbothioamide; CHEMBL483262; PKHFATUAFMXAKP-UHFFFAOYSA-N; amino[(cyclopentylideneazamethyl)amino]methane-1-thione; NSC8269; AC1Q7EGW; AC1LEPE5; SCHEMBL4100479; MolPort-000-248-728; KS-000027YL; NSC-8269; STK391362; BDBM50268200; SBB041172; ZINC17730060; AKOS000269515; MCULE-1053883982
|
||||||||||||||||||||||
Indication |
|
||||||||||||||||||||||
Drug Type |
Small molecular drug
|
||||||||||||||||||||||
Structure | |||||||||||||||||||||||
3D MOL | 2D MOL | ||||||||||||||||||||||
#Ro5 Violations (Lipinski): 0 | Molecular Weight (mw) | 157.24 | |||||||||||||||||||||
Logarithm of the Partition Coefficient (xlogp) | 0.2 | ||||||||||||||||||||||
Rotatable Bond Count (rotbonds) | 1 | ||||||||||||||||||||||
Hydrogen Bond Donor Count (hbonddonor) | 2 | ||||||||||||||||||||||
Hydrogen Bond Acceptor Count (hbondacc) | 2 | ||||||||||||||||||||||
Chemical Identifiers |
|
||||||||||||||||||||||
Cross-matching ID | |||||||||||||||||||||||
Molecular Interaction Atlas of This Drug
Drug Therapeutic Target (DTT) |
|
||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Molecular Interaction Atlas (MIA) | |||||||||||||||||||||||||||
Molecular Expression Atlas of This Drug
The Studied Disease | Discovery agent | |||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
ICD Disease Classification | N.A. | |||||||||||||||||||||||
|
||||||||||||||||||||||||
Molecular Expression Atlas (MEA) | ||||||||||||||||||||||||